Asia Pacific Insulin Infusion Pump Market Size, Share, and COVID-19 Impact Analysis, By Type (Patch and Tethered), By Accessories (Insulin Reservoir or Cartridges, Insulin Set Insertion Devices, and Battery), By End-use (Hospitals and Clinics, Homecare, and Laboratories), and Asia Pacific Insulin Infusion Pump Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Insulin Infusion Pump Market Insights Forecasts to 2035

• The Asia Pacific Insulin Infusion Pump Market Size was estimated at USD 328.0 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.52% from 2025 to 2035
• The Asia Pacific Insulin Infusion Pump Market Size is Expected to Reach USD 533.5 Million by 2035

The Asia Pacific Insulin Infusion Pump Market is anticipated to reach USD 533.5 million by 2035, growing at a CAGR of 4.52% from 2025 to 2035. The growing need for ambulatory infusion pumps in home care settings, along with the growing incidence of chronic diseases, is driving the insulin infusion pump market in the Asia Pacific region.

Market Overview

The Asia Pacific insulin infusion pump market is the industry encompassing the manufacturing, distribution, and sale of insulin pumps, which are used to deliver insulin to individuals with diabetes. An insulin infusion pump is a small, wearable device delivering insulin continuously throughout the day to mimic the way a healthy pancreas functions. Significant technological advancements in smart, interconnected, and automated systems, optimizing the precision and safety of infusion therapy, are propelling the insulin infusion pump market growth. The demand for advanced infusion management solutions, along with the adoption of specialty infusion pumps, is further bolstering the market growth for insulin infusion pump. The adoption of specialty infusion systems with a significant growth potential in emerging economies is providing market growth opportunities for insulin infusion pump.

Report Coverage

This research report categorizes the market for the Asia Pacific insulin infusion pump market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific insulin infusion pump market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific insulin infusion pump market.

Driving Factors

The growing use of ambulatory infusion pumps to deliver medications parenterally in hospitals, long-term care facilities, and patients' homes is driving the insulin infusion pump market. The growing burden of chronic diseases and ageing populations is driving the need for managing chronic conditions is contributing to propelling the market demand. The preference for insulin pump therapy, as well as growing health expenditure, awareness about diabetes management, and development of more user-friendly & technologically advanced pumps, is promoting the market for insulin infusion pump.

Restraining Factors

An increased cost of insulin pumps and associated consumables, along with potential safety concerns and strict regulations, are challenging the insulin infusion pump market. Further, the availability of alternative products is challenging the market growth of insulin infusion pump.

Market Segmentation

The Asia Pacific insulin infusion pump market share is classified into type, accessories, and end-use.

• The tethered segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific insulin infusion pump market is segmented by type into patch and tethered. Among these, the tethered segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. A tethered insulin infusion pump delivers insulin continuously through a thin tube (infusion set) connected to a cannula inserted under the skin. The reliability and availability of various products of the tethered insulin infusion pump are driving the market growth.

• The insulin set insertion devices segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific insulin infusion pump market is segmented by accessories into insulin reservoir or cartridges, insulin set insertion devices, and battery. Among these, the insulin set insertion devices segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The device is used to aid in inserting the infusion set cannula (a small, flexible tube) into the skin for insulin pump therapy. The use of an insulin infusion pump in general infusion sets of insulin pumps is responsible for driving the market growth in the insulin set insertion devices segment.

• The hospitals and clinics segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific insulin infusion pump market is segmented by end-use into hospitals and clinics, homecare, and laboratories. Among these, the hospitals and clinics segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Insulin infusion pumps are used to help manage blood sugar levels in patients with diabetes, offering an alternative to multiple daily injections. The availability of skilled healthcare experts, along with the increasing government investment contributing to driving the market in the hospitals and clinics segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific insulin infusion pump market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Medtronic
• Insulet
• Roche
• Animas
• Tandem
• Terumo
• Ypsomed
• Cellnovo
• Others

Recent Developments:

• In April 2023, Medtronic plc, the global leader in medical technology, announced U.S. Food and Drug Administration (FDA) approval of its MiniMed 780G system with the Guardian 4 sensor requiring no fingersticks while in SmartGuard technology.
• In July 2022, the Albanese Government is delivering on its election commitment to give all 130,000 Australians with Type 1 diabetes access to subsidised CGM products under the National Diabetes Services Scheme (NDSS).

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Insulin Infusion Pump Market based on the below-mentioned segments:

Asia Pacific Insulin Infusion Pump Market, By Type

• Patch
• Tethered

Asia Pacific Insulin Infusion Pump Market, By Accessories

• Insulin Reservoir or Cartridges
• Insulin Set Insertion Devices
• Battery

Asia Pacific Insulin Infusion Pump Market, By End-use

• Hospitals and Clinics
• Homecare
• Laboratories